Lipopolysaccharide inhibits the expression of resistin in adipocytes

  1. Weizhen Zhang1,4
  1. 1Department of Physiology and Pathophysiology, Peking University Health Science Center; Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing 100191, China
    2Department of Pathology, Central Hospital of Zibo, Zibo 255000, China
    3Division of Medicine, Memorial University of Newfoundland, St John's, Newfoundland, Canada
    4Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
  1. Correspondence should be addressed to W Zhang or Y Li, Emails: weizhenzhang{at}bjmu.edu.cn or yinli{at}bjmu.edu.cn)
  1. Figure 1

    Improvement of OGTT by LPS. Acute effect of LPS: 129 male mice were injected (i.p.) with a single high dose (1 mg/kg body weight) (A) or low dose (80 μg/kg body weight) (B) of LPS and OGTT was analyzed 24 h later. Control animals received PBS. n=6, data were expressed as means±s.e.m. and analyzed by two-way ANOVA or unpaired Student's t-test, *P<0.05 vs PBS. Total AUCs were calculated with y values set at zero. Chronic effect of LPS: 129 male mice received a daily i.p. injection of LPS (80 μg/kg body weight per day) for 7 days, and OGTT was examined. Control animals were treated with PBS injection in the same volume amount (C). n=6, data were expressed as means±s.e.m. and analyzed by two-way ANOVA or unpaired Student's t-test, *P<0.05 vs PBS. Total AUCs were calculated with y values set at zero.

  2. Figure 2

    Down-regulation of resistin by LPS in adipose tissues. (1) In vivo effects. Expression of resistin mRNA (A) and protein (B) in lean mice treated with LPS (80 μg/kg body weight per day) for 7 days. Resistin mRNA (C) and protein (D) in db/db mice treated with LPS (100 μg/kg body weight per day) for 7 days. Resistin mRNA levels are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01 compared with PBS group, n=6. (2) Effects in cultured adipocytes and ex vivo adipose tissues. Time-dependent response to 1000 ng/ml LPS in primary adipocytes (E), 3T3-L1 adipocytes (I) and adipose tissue fragments (L). Dose-dependent response to LPS treatment for 24 h in primary adipocytes (F), 3T3-L1 adipocytes (J) and adipose tissue fragments (M). Reversible effect of LPS on resistin expression. Adipocytes (G) and adipose tissues (N) were treated with LPS (300 ng/ml) for 8, 24, or 8 h then withdrawal of LPS for 16 h. Effect on resistin protein levels in primary rat adipocytes (H) and 3T3-L1 cells (K) treated with 1000 ng/ml LPS for 24 h. Resistin mRNA levels are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01 compared with PBS group; #P<0.05, ##P<0.01 compared with LPS (300 ng/ml) treatment for 24 h, 8 h groups; n=6.

  3. Figure 3

    Lipid A moiety-dependent effect. Effects of LPS (300 ng/ml), detoxified LPS (300 ng/ml) or lipid A (300 ng/ml) on resistin levels in adipose tissue fragments (A), primary adipocytes (B) and 3T3-L1 cells (C). Effect of PMB (500 U/ml) in ex vivo culture of adipose tissues (D), primary adipocytes (E) and 3T3-L1 adipocytes (F). Resistin mRNA levels are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.01 compared with PBS group; #P<0.05, ##P<0.01, LPS+PMB group compared with LPS group; n=6.

  4. Figure 4

    LPS down-regulates resistin expression by a transcriptional mechanism. Effect of LPS (300 ng/ml) on the half-life of resistin mRNA levels in 3T3-L1 adipocytes (A) and in primary rat adipocytes (B) in the presence of 5 μg/ml actinomycin D. Effect of LPS on resistin promoter activity by the luciferase activity of resistin-luc (4137 bp) induced by 24 h treatment with 300 ng/ml LPS relative to the control vehicle (C). Resistin mRNA levels are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by two-way ANOVA or unpaired Student's t-test. *P<0.01 compared with PBS group; n=6.

  5. Figure 5

    JNK-dependent effect. Effects of LPS (1000 ng/ml) or lipid A (1000 ng/ml) on JNK phosphorylation in 3T3-L1 adipocytes (A). Blockade of TLR4 by PMB (500 U/ml) completely attenuated the phosphorylation of JNK induced by LPS (1000 ng/ml) in 3T3-L1 adipocytes (B). Inhibition of JNK phosphorylation by SP600125 (20 μM) significantly blocked the effect of LPS (1000 ng/ml) on resistin expression in primary rat adipocytes (C) and 3T3-L1 adipocytes (D). Resistin mRNA levels are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.01 compared with PBS group; #P<0.01, LPS+PMB group compared with LPS group or LPS+SP600125 group compared with LPS group; n=6.

  6. Figure 6

    CHOP-10-dependent effect. Effect of LPS (1000 ng/ml) on CHOP-10 mRNA expression in adipose tissues (A) and in cultured 3T3-L1 adipocytes (B). The protein level of CHOP-10 in the presence of 1000 ng/ml LPS for 24 h in 3T3-L1 adipocytes (C). Blockade of JNK phosphorylation by SP600125 (20 μM) markedly attenuated the decrement of CHOP-10 mRNA (D) and protein (E) in cultured 3T3-L1 adipocytes. Over-expression of CHOP-10 blocked the inhibitory effect of LPS on the resistin mRNA (F). mRNA levels of CHOP-10 and resistin are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.05, **P<0.01 compared with PBS group; #P<0.05, ##P<0.01 LPS+SP600125 group compared with LPS group or LPS+antisense CHOP-10 group compared with LPS+missense CHOP-10 group; n=6.

  7. Figure 7

    C/EBP-α-dependent modulation. Effect of LPS (1000 ng/ml) on C/EBP-α mRNA expression in adipose tissues (A) and in cultured 3T3-L1 adipocytes (B). The protein level of C/EBP-α in the presence of 1000 ng/ml LPS for 24 h in 3T3-L1 adipocytes (C). Blockade of JNK phosphorylation by SP600125 (20 μM) markedly attenuated the decrement of C/EBP-α mRNA (D) and protein (E) in cultured 3T3-L1 adipocytes. Over-expression of C/EBP-α blocked the inhibitory effect of LPS on the resistin mRNA (F). mRNA levels of C/EBP-α and resistin are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. *P<0.01 compared with PBS group; #P<0.01 LPS+SP600125 group compared with LPS group or LPS+C/EBP-α plasmid group compared with LPS+GFP plasmid group; n=6.

  8. Figure 8

    PPAR-γ-dependent regulation. Effect of LPS (1000 ng/ml) on PPAR-γ mRNA expression in adipose tissues (A) and in cultured 3T3-L1 adipocytes (B). The protein level of PPAR-γ in 3T3-L1 adipocytes treated with 1000 ng/ml LPS for 24 h (C). Blockade of JNK phosphorylation by SP600125 (20 μM) markedly attenuated the decrement of PPAR-γ mRNA (D) and protein (E) in cultured 3T3-L1 adipocytes. Activation of PPAR-γ by rosiglitazone (1 μM) (F), or by over-expression of PPAR-γ (G) blocked the inhibitory effect of LPS on the resistin mRNA. mRNA levels of PPAR-γ and resistin are normalized to β-actin mRNA levels, and the results are mean±s.e.m. of three independent experiments and analyzed by one-way ANOVA. **P<0.01 compared with PBS group; #P<0.05, LPS+rosiglitazone group compared with LPS group, ##P<0.01 LPS+SP600125 group compared with LPS group or LPS+PPAR-γ adenoviral vectors group compared with LPS+adenoviral vectors group; n=6.

  9. Figure 9

    Illustration of signaling pathways. LPS modulates resistin expression through the TLR4-JNK-CHOP-10-C/EBP-α/PPAR-γ signaling.

| Table of Contents